BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 38751868)

  • 1. Screening, expression and anti-tumor functional identification of anti-LAG-3 nanobodies.
    Jiang D; Chen R; Wang L; Xu G
    Protein Expr Purif; 2024 Jun; 222():106522. PubMed ID: 38851552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy to generate nanobodies for the coumaphos based on the synthesized nanobody libraries.
    Fang R; Li Y; Liu F; Liang Y; Wang Y; Zhong G; Xu Z; Hammock BD; Wang H
    Food Chem; 2024 May; 455():139684. PubMed ID: 38833869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and construction of nanobodies against human CD93 using phage libraries and study of their antiangiogenic effects.
    Miao H; Wu Y; Ouyang H; Zhang P; Zheng W; Ma X
    Front Bioeng Biotechnol; 2024; 12():1372245. PubMed ID: 38751868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for p19 Targeting by Anti-IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis.
    Daniele SG; Eldirany SA; Damiani G; Ho M; Bunick CG
    JID Innov; 2024 Mar; 4(2):100261. PubMed ID: 38445231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin.
    Lugano R; Vemuri K; Barbera S; Orlandini M; Dejana E; Claesson-Welsh L; Dimberg A
    FASEB J; 2023 Apr; 37(4):e22894. PubMed ID: 36961390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of therapeutic antibodies for the treatment of diseases.
    Wang Z; Wang G; Lu H; Li H; Tang M; Tong A
    Mol Biomed; 2022 Nov; 3(1):35. PubMed ID: 36418786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Library Screening Using Yeast Biopanning and Fluorescence-Activated Cell Sorting.
    Carrara SC; Bogen JP; Grzeschik J; Hock B; Kolmar H
    Methods Mol Biol; 2022; 2491():177-193. PubMed ID: 35482191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages.
    Mahdavi SZB; Oroojalian F; Eyvazi S; Hejazi M; Baradaran B; Pouladi N; Tohidkia MR; Mokhtarzadeh A; Muyldermans S
    Int J Biol Macromol; 2022 May; 208():421-442. PubMed ID: 35339499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem.
    Honorato RV; Koukos PI; Jiménez-García B; Tsaregorodtsev A; Verlato M; Giachetti A; Rosato A; Bonvin AMJJ
    Front Mol Biosci; 2021; 8():729513. PubMed ID: 34395534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.
    Sun Y; Chen W; Torphy RJ; Yao S; Zhu G; Lin R; Lugano R; Miller EN; Fujiwara Y; Bian L; Zheng L; Anand S; Gao F; Zhang W; Ferrara SE; Goodspeed AE; Dimberg A; Wang XJ; Edil BH; Barnett CC; Schulick RD; Chen L; Zhu Y
    Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expasy, the Swiss Bioinformatics Resource Portal, as designed by its users.
    Duvaud S; Gabella C; Lisacek F; Stockinger H; Ioannidis V; Durinx C
    Nucleic Acids Res; 2021 Jul; 49(W1):W216-W227. PubMed ID: 33849055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD93 negatively regulates astrogenesis in response to MMRN2 through the transcriptional repressor ZFP503 in the developing brain.
    Liang Q; Su L; Zhang D; Jiao J
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9413-9422. PubMed ID: 32291340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of therapeutic antibodies for the treatment of diseases.
    Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
    J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
    Ferrari D; Garrapa V; Locatelli M; Bolchi A
    Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
    Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
    Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-survivin single-domain antibodies derived from an artificial library including three synthetic random regions by in vitro selection using cDNA display.
    Suzuki T; Mochizuki Y; Kimura S; Akazawa-Ogawa Y; Hagihara Y; Nemoto N
    Biochem Biophys Res Commun; 2018 Sep; 503(3):2054-2060. PubMed ID: 30119893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
    Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
    J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into a high affinity nanobody:antigen complex by homology modelling.
    Skottrup PD
    J Mol Graph Model; 2017 Sep; 76():305-312. PubMed ID: 28779687
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.